Literature DB >> 32120346

When Increase in Serum Creatinine Doesn't Imply Kidney Damage.

Linda Fried1.   

Abstract

Entities:  

Keywords:  acute kidney injury; angiotensin receptor antagonists; angiotensin-converting enzyme inhibitors; chronic renal insufficiency; creatinine; diabetic nephropathies; fibrosis; heart failure; humans; length of stay; sodium-glucose transport proteins; sodium-glucose transporter 2 inhibitors

Mesh：

Substances：

Year:  2020        PMID： 32120346      PMCID： PMC7057294          DOI： 10.2215/CJN.14521119

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

Review 1.  Renal Effects of Sodium-Glucose Co-Transporter Inhibitors.

Authors:  Scott C Thomson; Volker Vallon
Journal:  Am J Cardiol       Date:  2019-12-15       Impact factor: 2.778

Review 2.  Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials.

Authors:  Steven G Coca; Azadeh Zabetian; Bart S Ferket; Jing Zhou; Jeffrey M Testani; Amit X Garg; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 10.121

3.  An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.

Authors:  Frank A Holtkamp; Dick de Zeeuw; Merlin C Thomas; Mark E Cooper; Pieter A de Graeff; Hans J L Hillege; Hans-Henrik Parving; Barry M Brenner; Shahnaz Shahinfar; Hiddo J Lambers Heerspink
Journal:  Kidney Int       Date:  2011-03-30       Impact factor: 10.612

4.  Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.

Authors:  Marat Fudim; Rahul Loungani; Shannon M Doerfler; Adrian Coles; Stephen J Greene; Lauren B Cooper; Mona Fiuzat; Christopher M O'Connor; Joseph G Rogers; Robert J Mentz
Journal:  Am Heart J       Date:  2018-07-29       Impact factor: 4.749

5.  Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.

Authors:  Chi-Yuan Hsu; Dawei Xie; Sushrut S Waikar; Joseph V Bonventre; Xiaoming Zhang; Venkata Sabbisetti; Theodore E Mifflin; Josef Coresh; Clarissa J Diamantidis; Jiang He; Claudia M Lora; Edgar R Miller; Robert G Nelson; Akinlolu O Ojo; Mahboob Rahman; Jeffrey R Schelling; Francis P Wilson; Paul L Kimmel; Harold I Feldman; Ramachandran S Vasan; Kathleen D Liu
Journal:  Kidney Int       Date:  2016-10-28       Impact factor: 10.612

6.  The prognostic importance of different definitions of worsening renal function in congestive heart failure.

Authors:  Stephen S Gottlieb; William Abraham; Javed Butler; Daniel E Forman; Evan Loh; Barry M Massie; Christopher M O'connor; Michael W Rich; Lynne Warner Stevenson; James Young; Harlan M Krumholz
Journal:  J Card Fail       Date:  2002-06       Impact factor: 5.712

7.  Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status in diabetic children.

Authors:  F Ginevri; E Piccotti; R Alinovi; T DeToni; C Biagini; G M Chiggeri; R Gusmano
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 8.  Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis.

Authors:  Le-Ting Zhou; Lin-Li Lv; Ming-Ming Pan; Yu-Han Cao; Hong Liu; Ye Feng; Hai-Feng Ni; Bi-Cheng Liu
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.

Authors:  Rakesh Malhotra; Ronit Katz; Vasantha Jotwani; Walter T Ambrosius; Kalani L Raphael; William Haley; Anjay Rastogi; Alfred K Cheung; Barry I Freedman; Henry Punzi; Michael V Rocco; Joachim H Ix; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-28       Impact factor: 8.237
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.